Eurofins Genomics - Pop Gen - Population scale screening arrays

Services for population genomics initiatives

Your European partner for population scale genomics

Leverage our scalable infrstructure.

 

 

Speak to our expert

Custom solutions for unique challenges

Benefit from our consultative approach to navigating complex projects with ease

icon

Automation

We offer streamlined, fast, stable and improved processes with our advanced automation technologies.

icon

Scalability

Easily expand your sample volumes to according to your project with our scalable solutions.

icon

Multiomics

Integrate diverse data types for comprehensive insights through our multiomics approach.

icon

Local Provider

Benefit from EU standards and on site support by a trusted and well known local provider.

icon

Highest Accreditation Level

Rest assured, our laboratory meets the highest standards of quality and reliability, accredited to ISO 15189.

icon

Skilled Scientists

Our team of skilled scientists brings expertise and innovation to every project.

Multiomics Overview

Designed to meet the unique demands of your project

Explore all available options

Genomics

Key Insights for Disease Genetics and Public Health

Genomics is pivotal in population health research, offering insights into disease genetics and aiding personalized medicine. Techniques like genotyping identify genetic markers for health conditions, while next-generation sequencing uncovers broader genetic variations. These tools are essential in epidemiological studies, helping to track disease trends and inform public health strategies, ultimately advancing our understanding of the genetic basis of diseases and their impact on populations.

icon

Platforms

  • Illumina
  • Thermo Fisher
  • MGI
  • Oxford Nanopore (Long-Read)
icon

Workflows

  • Whole Genome Sequencing
  • Sequencing only
  • Whole exome sequencing
  • Shotgun metagenomics

Epigenomics

Bridging Genetics and Environmental Factors in Disease Development

Epigenomics, exploring beyond genetic sequences to how genes are expressed, is crucial in population health studies. It helps in understanding how environmental factors and lifestyle choices influence gene expression, contributing to disease development. This field is key in unraveling the complex interplay between genetics and the environment, providing a more comprehensive picture of health and disease mechanisms, highlighting how external factors can shape genetic outcomes.

icon

Platforms

  • Oxford Nanopore (Long-Read)
  • Illumina
  • MGI

 

icon

Workflows

  • Long read on Oxford Nanopore
  • Bisulphite sequencing
  • Enzymatic conversion
  • Illumina EPIC & MSA arrays

 

Transcriptomics

Exploring RNA Transcripts: Insights into Gene Regulation

Transcriptomics is a vital component in population health research, focusing on the study of RNA transcripts to understand gene expression patterns. This field has become even more relevant with the identification of over 190 RNA modifications, which add another layer of complexity to gene expression regulation. By analyzing these RNA molecules, transcriptomics provides critical insights into how genes are activated or silenced in different health conditions, offering a deeper understanding of disease mechanisms and potential therapeutic targets.

icon

Platforms

  • Oxford Nanopore (Long-Read)
  • Illumina
  • Thermo Fisher
  • MGI
icon

Workflows

  • RNS seq

Proteomics

Bridging Genotype and Phenotype in Health Studies

Proteomics, the study of proteins, is fundamental in population health research. It delves into protein structures, functions, and interactions, providing crucial insights into various biological processes and disease mechanisms. Understanding protein dynamics helps in identifying biomarkers for diseases and potential therapeutic targets, enhancing disease diagnosis and treatment strategies. Proteomics is key in understanding the functional implications of genetic information, bridging the gap between genotype and phenotype in population health studies.

icon

Platforms

  • Olink
  • Somalogic
  • Illumina

 

icon

Workflows

  • Olink Explore HT
  • Olink targetted panels
  • SomaScan panels

 

***Early Access***

Accelerate your research with the next-generation SOMAmer Plasma Proteomics and Illuminas´s NovaSeq X Plus System

Unlock the future of Proteomics. Download the full protein list today and explore the precision of SOMAmer for breakthrough discoveries.

 

 

Register for free Webinar

LEARN MORE

icon

Genotyping

Population health screening leverages next-generation sequencing and high-throughput genotyping to identify genetic risk factors, enabling targeted interventions in large populations.

LEARN MORE
icon

NGS

Next-generation sequencing (NGS) enables rapid and cost-effective sequencing of entire genomes, allowing for comprehensive genetic analysis and insights into disease susceptibility and treatment.

LEARN MORE
icon

Long Read

Long-read sequencing technology provides high-resolution genomic data by accurately mapping complex regions of DNA, enhancing our understanding of structural variations and improving disease detection.

LEARN MORE
icon

Proteomics

Proteomics uses advanced techniques like mass spectrometry to analyze protein expression and interactions, facilitating insights into disease mechanisms and potential therapeutic targets.

LEARN MORE

Multiomics Overview

Designed to meet the unique demands of your project

Explore all available options

 

Microarrays

Genotyping by Microarrays

Population scale screening arrays combine universal genome-wide content, curated clinical research variants and QC markers.

icon

Genome-wide multiethnic GWAS backbone

  • Build on whole-genome reference data from 1000 genomes
  • Global content is cross-population and population specific

 

icon

Laboratory information management system

  • Disease and trait associated markers (ClinVar / PharmGKB / NHGR-EBI)
  • Cross-population and population specific exonic content
  • HLA alleles and extended MHC region.

 

 

icon

Quality control markers

  • Sample identification / tracking, ancestry determination, stratification

 

 

NGS

Next Generation Sequencing

The midplex genotyping approach is highly accurate, robust, cost-efficient, flexible and customisable.

icon

SNP biomarker validation

  • Population screening
  • Biobank screening (retrospective analysis of germline SNPs)
  • Disease screening.
icon

Accuracy and robustness

  • On average > 97% successful SNP design and > 98% sample call rate
  • Low DNA amounts needed (20 ng): Crude DNA extraction possible for blood, tissue and cells
  • High multiplexing capabilities at low costs and fast TAT (1 – 3 weeks).

 

icon

Flexibility and customisation

  • Completely customized sets of SNPs (10 – 1,000)
  • Additional samples can be added any time
  • Flexible system allowing implementation of additional SNPs at a later stage
  • Analysis of either one SNP or several SNPs per target region

 

Low Pass Sequencing

Next Generation Genotyping by Low Pass Sequencing

Discover biomarkers with cost-efficient “Low Pass Whole Genome Sequencing”.

icon

Low pass whole genome sequencing

  • < 10x coverage
  • 150 paired-end sequencing on NovaSeq 6000

 

icon

Cost-efficient alternative to WGS

  • Detection of noven SNPs
  • Missing genomic region can be filled by “imputation”

 

icon

Ideal for large scale projects

  • Population screening of a > 15.000 patient cohort from a biobank

 

Most relevant applications

  • Genome-wide association studies (GWAS)
  • Population screening
  • Ancestry analysis
  • Biobank profiling
  • Investigation of complex diseases

References

Project Examples



Our Future Health, UK

Eurofins Genomics partners in pioneering UK health project, providing advanced genotyping for 5 million participants. Advancing precision medicine and personalised healthcare with an unwavering commitment to genomic advancements. Upholding the highest standards for quality, accuracy, and efficiency in genotyping services. Working with partners to revolutionise healthcare through genomics.

Work conducted by Eurofins Genomics:

  • Genotyping will be performed on illumina custom array with 700k SNPs
  • We are building a dedicated lab in UK
  • The goal of the Our Future Health program is to facilitate the discovery and development of new methods of prevention, early detection and treatment of a wide range of diseases
  • Today, 59% of UK citizens aged 65 years or older have two or more serious health conditions, and this statistic has been projected to reach 70% by 2035. With the recruitment of five million adult volunteers, this research program has the potential to improve the long-term health of millions of people in the UK and globally. The insights gained into links between DNA and diseases through this program will accelerate the development of innovative solutions to help people to live healthier lives for longer.


 


The Simpler Project, Uppsala University

The infrastructure SIMPLER consists of questionnaire data and biological samples for research on how dietary, lifestyle factors and genetics affect health, especially during the latter part of life.

Work conducted by Eurofins Genomics:

  • DNA extraction of 38.000 saliva and blood samples
  • Genotyping on microarrays of 40.500 samples
  • The success rate (sample to genotype) has been extremely high, above 99%
  • The project began in late spring 2019 and was completed on time as scheduled at the end of 2020
  • Genotyping was performed on the Illumina Infinium Global Screening Array (GSA MD 3.0)

“We are very happy with Eurofins’ competence and professional approach” comments Anna-Karin Kolseth, project coordinator, SIMPLER.

 

Low-Pass Sequencing for "Top-20 Pharmaceutical Company"

Fast, cost-efficient and high throughput Next Generation Sequencing for Top 20 pharma client.

Sucessfully completed a few weeks time 18.000 sample cohort up to 2.500 WGS samples per week.

Work conducted by Eurofins Genomics:

  • Dedicated, pro-active Consulting & Project Management
  • Incl. Weekly update calls
  • Tailored Quality Control reports
  • Customized Data Transfers

Free consulting for your population genomics project

Speak to our population genomics experts about your ideas

Our team of experts can advise and assist you with all the information on our end-to-end service offer.



Approved by your peers from Ancestry, Genealogy, Health & Wellness

We are a trusted population genomics brand around the globe

icon

We cooperate with renowned organisations, ranging from small to large-scale enterprises to provide ‘best-in-class’ genomic services to both established and new, emerging consumer genomics markets. Scientists around the world recognise and trust the Eurofins brand for its reputation for quality, timeliness and efficiency. We host only industry-leading platforms for DNA extraction, genotyping, sequencing and related consumer genomics applications.

LEARN MORE

Meet our wordclass laboratories

Denmark and UK

Highly specialized laboratories are essential for conducting advanced analyses, such as NGS and proteomics, as they ensure precision, accuracy, and adherence to stringent quality standards, ultimately enhancing the reliability of diagnostic and research outcomes.

Welcome to our state-of-the-art genomics lab in Galten, Denmark, established in 2019. As the largest array laboratory in Europe, we specialize in population health through advanced automation technologies. Our cutting-edge facility is dedicated to delivering precise genomic analyses that enhance public health outcomes and support innovative research initiatives. Join us in our mission to transform healthcare through the power of genomics!

Welcome to our state-of-the-art genomics lab in Galten, Denmark, established in 2019. As the largest array laboratory in Europe, we specialize in population health through advanced automation technologies. Our cutting-edge facility is dedicated to delivering precise genomic analyses that enhance public health outcomes and support innovative research initiatives. Join us in our mission to transform healthcare through the power of genomics!

Quality you can rely on

Work with a fully certified population genomics partner

 

icon

ISO 17025

Guaranteed confidentiality and integrity of testing data. 


Testing results are recognised by authorities and customs, etc. for the release of pharmaceuticals and food and feed, in the case of legal implications.

icon

ISO 15189

SO 15189 is an international standard for medical laboratories that focuses on quality management and competence.

 
It requires laboratories to establish a quality management system, ensure staff competency, maintain suitable facilities and equipment, and control documents and records. The standard promotes continual improvement and emphasizes accurate, reliable test results to enhance patient safety and healthcare delivery.

 

 

icon

GDPR

All data is stored and processed on German servers.


We do not share data with third parties.


Only necessary data is requested.


Customer data is stored using the most advanced security tools.

Customer voice

“We are very happy to work with Eurofins Genomics because it has allowed us to absorb our exponential growth in the number of samples analysed, while maintaining exceptional process quality.”

RAMÓN CATALÁ · CEO TELLMEGEN

RAMÓN CATALÁ · CEO TELLMEGEN

“Not only do they have one of the most advanced laboratories in Europe, but also the human team behind them is amazing. We look forward to continuing to grow with them.”

RAMÓN CATALÁ · CEO TELLMEGEN

RAMÓN CATALÁ · CEO TELLMEGEN

 

Your dedicated Population Genomics Experts

MEET OUR TEAM

Ask us anything about genomics along your value chain — we’re happy to help.